MARINA TSIVIN: Open Payments
NPI 1114439130 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 20 payments from 7 companies in 2025. Trend: 2023 $81 · 2024 $368 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $366 |
| Novo Nordisk Inc | 4 | $112 |
| Renalytix AI, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Lilly USA, LLC | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
Products named: Yeztugo, Ozempic, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, SHINGRIX, AREXVY, MOUNJARO, TRUMENBA, LOREEV XR.
Industry payments across NY — which companies pay providers there.
